These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38519049)

  • 81. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
    Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
    Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis.
    Qi X; Jia J; Bai M; Guo X; Su C; García-Pagán JC; Han G; Fan D
    J Clin Gastroenterol; 2015 Jul; 49(6):495-505. PubMed ID: 25127113
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    Roccarina D; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Benmassaoud A; Plaz Torres MC; Iogna Prat L; Csenar M; Arunan S; Begum T; Milne EJ; Tapp M; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013121. PubMed ID: 33822357
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020.
    Horhat A; Bureau C; Thabut D; Rudler M
    United European Gastroenterol J; 2021 Mar; 9(2):203-208. PubMed ID: 32819214
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.
    Pfisterer N; Riedl F; Pachofszky T; Gschwantler M; König K; Schuster B; Mandorfer M; Gessl I; Illiasch C; Fuchs EM; Unger L; Dolak W; Maieron A; Kramer L; Madl C; Trauner M; Reiberger T
    Liver Int; 2019 Feb; 39(2):290-298. PubMed ID: 30248224
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Outcomes of Transjugular Intrahepatic Portosystemic Shunt and Gastric Coronary Vein Embolization for Variceal Bleeding in Cirrhotic Portal Hypertension.
    Mukhiya G; Han X; Jiao D; Bi Y; Pokhrel G; Liu Z; Li Z; He Y
    Clin Med Res; 2023 Sep; 21(3):144-154. PubMed ID: 37985166
    [No Abstract]   [Full Text] [Related]  

  • 88. [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices].
    Song HG; Lee HC; Park YH; Jung S; Chung YH; Lee YS; Yoon HK; Sung KB; Suh DJ
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):448-57. PubMed ID: 12506249
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed.
    Mukund A; Vasistha S; Jindal A; Patidar Y; Sarin SK
    Hepatol Int; 2023 Aug; 17(4):954-966. PubMed ID: 36787012
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D; Sturm L; Pfaff L; Hahn F; Kloeckner R; Volkwein L; Praktiknjo M; Lv Y; Han G; Huber JP; Boettler T; Reincke M; Klinger C; Caca K; Heinzow H; Seifert LL; Weiss KH; Rupp C; Piecha F; Kluwe J; Zipprich A; Luxenburger H; Neumann-Haefelin C; Schmidt A; Jansen C; Meyer C; Uschner FE; Brol MJ; Trebicka J; Rössle M; Thimme R; Schultheiss M
    J Hepatol; 2021 Jun; 74(6):1362-1372. PubMed ID: 33508376
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The use of transjugular intrahepatic portosystemic stent shunt (TIPS) in the management of portal hypertensive bleeding.
    Lo GH
    J Chin Med Assoc; 2014 Aug; 77(8):395-402. PubMed ID: 25028297
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
    Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
    Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
    Gülberg V; Schepke M; Geigenberger G; Holl J; Brensing KA; Waggershauser T; Reiser M; Schild HH; Sauerbruch T; Gerbes AL
    Scand J Gastroenterol; 2002 Mar; 37(3):338-43. PubMed ID: 11916197
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results.
    Hermie L; Biervliet SV; Hoorens A; Cauwenberghe LV; Robberecht E; Defreyne L
    Diagn Interv Radiol; 2024 Jan; 30(1):55-64. PubMed ID: 36994654
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transjugular intrahepatic portasystemic stent-shunt in the treatment of variceal haemorrhage.
    Jalan R; Redhead DN; Hayes PC
    Br J Surg; 1995 Sep; 82(9):1158-64. PubMed ID: 7551988
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Outcomes of transjugular intrahepatic portosystemic shunt using 12 mm diameter polytetrafluoroethylene covered stents in cirrhotic patients with portal hypertension.
    Habash M; Murray A; Heeke B; Mahmoud K; Li Y; Saddekni S; Abdel Aal AK; Gunn AJ
    Diagn Interv Radiol; 2022 May; 28(3):239-243. PubMed ID: 35748206
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives.
    Gairing SJ; Müller L; Kloeckner R; Galle PR; Labenz C
    Aliment Pharmacol Ther; 2022 May; 55(10):1265-1276. PubMed ID: 35181894
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Primary implantation of polyester-covered stent-grafts for transjugular intrahepatic portosystemic stent shunts (TIPSS): A pilot study.
    Cejna M; Thurnher S; Pidlich J; Kaserer K; Schoder M; Lammer J
    Cardiovasc Intervent Radiol; 1999; 22(4):305-10. PubMed ID: 10415220
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Secondary prophylaxis of oesophageal variceal haemorrhage: a role for transjugular intrahepatic portosystemic shunt?
    Harrison P; Karani J
    Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):591-3. PubMed ID: 12072591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.